Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aegon N.V. Major Shareholding Notification 2019

Jul 1, 2019

3803_rns_2019-07-01_f2fbc119-7ffb-42f3-b459-b2bf421b4048.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates
Company dealt in AbbVie Inc.
Class of relevant security to which

the dealings being disclosed relate
(Note 2)
US$0.01 common stock
Date of dealing 28th June 2019

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 67,521,790 4.56733%
(2) Derivatives (other than options) N/A
(3) Options and agreements to

purchase/sell
N/A
Total 67,521,790 4.56733%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities N/A
(2) Derivatives (other than options) N/A
(3) Options and agreements to purchase/sell N/A
Total N/A

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5)
Purchase 200 72.72
Purchase 7,900 72.72
Purchase 400 72.72
Purchase 1,100 72.72
Purchase 7,400 72.72
Purchase 2,600 72.72
Purchase 400 72.72
Purchase 29,100 72.72
Purchase 400 72.72
Purchase 4,000 72.72
Purchase 182 72.72
Purchase 6,300 72.72
Purchase 800 72.72
Purchase 200 72.72
Purchase 1,400 72.72
Purchase 500 72.72
Purchase 3,200 72.72
Purchase 5,300 72.72
Purchase 1,700 72.64
Purchase 300 72.72
Purchase 68 72.72
Purchase 520 72.72
Purchase 35,480 72.72
Purchase 5,922 72.72
Purchase 684 72.72
Purchase 686 72.72
Purchase 1,782 72.72
Purchase 300 72.72
Purchase 130 72.72
Purchase 600 72.72
Purchase 1,600 72.72
Purchase 1,500 72.72
Purchase 1,111 72.72
Purchase 1,200 72.72
Sale 5,700 72.72
Sale 500 72.72
Sale 1,800 72.72
Sale 2,100 72.72
Sale 700 72.72
Sale 366 72.72
Sale 300 72.72
Sale 1,600 72.72
Sale 400 72.72
Sale 400 72.72
Sale 18,900 72.72
Sale 3,800 72.72
Sale 900 72.72
Sale 4,900 72.72
Sale 13,200 72.72
Sale 6,100 72.72
Sale 4,000 72.72
Sale 4,700 72.72
Sale 600 72.72
Sale 3,705 72.72
Sale 1,530 72.72
Sale 2,300 72.72
Sale 1,600 72.72
Sale 1,000 72.72
Sale 300 72.72
Sale 1,100 72.72
Sale 800 72.72
Sale 200 72.72
Sale 500 72.72
Sale 8,900 72.72
Sale 6,700 72.72
Sale 1,500 72.72
Sale 114 72.72
Sale 1,700 72.72

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction



(Note 6)
Number of relevant securities



(Note 7)
Price per unit



(Note 5)
N/A

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling,

purchasing

 varying etc.
Number of

securities to which

the option relates

(Note 7)
Exercise

price
Type, e.g.

American,

European etc.
Expiry

date
Option money

paid/received

per unit
(Note 5)
N/A

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per

unit
(Note 5)
N/A

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable)
(Note 5)
N/A

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A
Is a Supplemental Form 8 attached? (Note 9) NO





Date of disclosure 01st  July 2019
Contact name Chetan Shah
Telephone number +44 20 33956564
If a connected EFM, name of offeree/offeror with which connected N/A
If a connected EFM, state nature of connection (Note 10) N/A